Dr. Spiess on key penile and testis cancer research from AUA 2022

In this video, Philippe Spiess, MD, MS, FACS, recaps several presentations from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana. Spiess is a genitourinary oncologist and the assistant chief of surgical services at Moffitt Cancer Center in Tampa, Florida.

Among the abstracts discussed are:

1. PD51-06 (Konneh et al): Evaluation of Mir-371a-3p Performance in Detecting Seminomatous Testicular Cancer Metastases

2. MP46-02 (Lafin et al): Refinement of the Serum miR-371a-3p Test for the Detection of Chemotherapy-naive Minimal Residual Testicular Cancer

3. MP46-09 (Churchill et al): Does time to dynamic sentinel lymph node biopsy affect recurrence-free survival in penile squamous cell carcinoma?

4. MP46-11 (Nazzani et al): Bilateral inguinal lymphnode dissection versus inguinal lymphnode dissection and dynamic sentinel node biopsy in N1 squamous cell carcinoma of the penis